Philippe Mineur

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Lucien Noens, Marie-Anne van Lierde, R. De Bock et al. · Blood · 2009 · 606 citations · Full text

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

M. A. Boogaerts, Elihu H. Estey, Chatchada Karanes et al. · Leukemia · 2002 · 221 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +10

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

Pierre Fenaux, Sylvie Chevret, A. Guerci et al. · Leukemia · 2000 · 170 citations

Hematological Malignancy, Long-term Follow-up, Medicine +10

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications

Emerence Crompot, Michaël Van Damme, Karlien Pieters et al. · Haematologica · 2017 · 89 citations · Full text